Valencene synthase polypeptides, encoding nucleic acid molecules and uses thereof
Provided are valencene synthase polypeptides, nucleic acid molecules encoding the valencene synthases, host cells containing the nucleic acids and methods for producing products whose production is catalyzed by the polypeptides. Also provided are methods for producing valencene and nootkatone.
1. A nucleic acid molecule encoding a valencene synthase polypeptide, wherein:
the valencene synthase polypeptide has at least 95% sequence identity to the sequence of amino acids set forth in SEQ ID NO: 1;
the encoded valencene synthase catalyzes the formation of valencene from an acyclic pyrophosphate terpene precursor;
the nucleic acid molecule has at least 95% identity to SEQ ID NO: 2; and
the nucleic acid molecule is cDNA.
2. The nucleic acid molecule of claim 1 , wherein: the encoded valencene synthase polypeptide comprises the sequence of amino acids set forth in SEQ ID NO:1.
3. A vector, comprising a nucleic acid molecule that encodes a valencene synthase polypeptide, wherein:
the valencene synthase polypeptide has at least 95% sequence identity to a valencene synthase polypeptide whose sequence is set forth in SEQ ID NO: 1;
the encoded valencene synthase catalyzes the formation of valencene from an acyclic pyrophosphate terpene precursor;
the nucleic acid molecule has at least 95% identity to SEQ ID NO: 2; and
the nucleic acid molecule is cDNA.
4. The vector of claim 3 , wherein the vector is a prokaryotic vector or a eukaryotic vector.
5. The vector of claim 3 that is a viral vector.
6. The vector of claim 3 , wherein the vector is a yeast vector.
7. A host cell comprising the vector of claim 3 .
8. The host cell of claim 7 that is a prokaryotic cell or a eukaryotic cell.
9. The host cell of claim 7 that is selected from among a bacteria, yeast, insect, plant or mammalian cell.
10. The host cell of claim 9 that is a yeast cell and is a Saccharomyces genus cell or a Pichia genus cell.
11. The cell of claim 7 that produces farnesyl diphosphate natively or is modified to produce more farnesyl diphosphate compared to an unmodified cell.
12. The cell of claim 7 that is a plant cell.
13. A transgenic plant, comprising the vector of claim 3 .
14. A method for producing valencene, the method comprising:
culturing a yeast cell that contains the vector of claim 3 under conditions in which the encoded valencene synthase polypeptide is expressed and catalyzes production of valencene from an acyclic pyrophosphate terpene precursor, wherein:
the valencene synthase polypeptide is heterologous to the yeast cell; and
the yeast cell produces the acyclic pyrophosphate terpene precursor.
15. The method of claim 14 , wherein the acyclic pyrophosphate terpene precursor is farnesyl diphosphate.
16. The method of claim 14 , wherein the yeast cell is a Saccharomyces genus cell of a Pichia genus cell.
17. The method of claim 14 , wherein the cell is a Saccharomyces cerevisiae cell.
18. The method of claim 14 , further comprising isolating the valencene.
19. The method of claim 14 , further comprising oxidizing the valencene to nootkatone.
20. The method of claim 18 , further comprising oxidizing the valencene to nootkatone.
21. A method for producing nootkatone, the method comprising:
culturing the cell of claim 7 , wherein the cell is a yeast cell, under conditions in which the encoded valencene synthase polypeptide is expressed and catalyzes production of valencene from an acyclic pyrophosphate terpene precursor to produce valencene, wherein the yeast cell produces the acyclic pyrophosphate terpene precursor; and
oxidizing the valencene to produce nootkatone.
22. The method of claim 21 , wherein the acyclic pyrophosphate terpene precursor is farnesyl diphosphate.
23. The method of claim 21 , wherein the yeast cell yeast cell that is a Saccharomyces genus cell or a Pichia genus cell.
24. The method of claim 21 , wherein the yeast cell is a Saccharomyces cerevisiae cell.
25. The method of claim 21 , further comprising isolating the valencene before oxidizing the valencene to nootkatone.
26. The method of claim 14 , further comprising isolating aristolochene.
27. The nucleic acid molecule of claim 1 that is a nucleic acid sequence having the sequence set forth in SEQ ID NO: 3.
28. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule contains at least one substitution modification relative to SEQ ID NO: 2.
29. The vector of claim 3 , wherein the nucleic acid molecule contains at least one substitution modification relative to SEQ ID NO: 2.